23ANDME HOLDING CO. 2021 INCENTIVE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • May 25th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations • Delaware
This RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), dated as of [ ] (the “Date of Grant”), is delivered by 23andMe Holding Co. (the “Company”) to [ ] (the “Participant”).
RELINQUISHMENT AGREEMENTRelinquishment Agreement • May 25th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations • Delaware
This RELINQUISHMENT AGREEMENT (this “Agreement”) is made and entered into as of October 21, 2021, by and between 23andMe Holding Co., a Delaware corporation (“Parent”), and Paul Johnson (“Holder”).
Amendment No. 4 to Consulting Agreement and Statement of Work #1Consulting Agreement • May 25th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations
This Amendment No. 4 (“Amendment No. 4”) is to the Consulting Agreement by and between 23andMe, Inc. (“23andMe”) and Richard Scheller, Ph.D. (“Consultant”) with an Effective Date of April 1, 2019, and as amended (“Agreement”), including Statement of Work #1 (“SOW#1”) to the Agreement. Collectively, 23andMe and Consultant may be referred to as “Parties.” Capitalized terms not defined herein will have the meanings ascribed to them in the Agreement.
Amendment No. 3 to Consulting Agreement and Statement of Work #1Consulting Agreement • May 25th, 2023 • 23andMe Holding Co. • Pharmaceutical preparations
This Amendment No. 3 (“Amendment No. 3”) is to the Consulting Agreement by and between 23andMe, Inc. (“23andMe”) and Richard Scheller, Ph.D. (“Consultant”) with an Effective Date of April 1, 2019, and as amended (“Agreement”), including Statement of Work #1 (“SOW#1”) to the Agreement. Collectively, 23andMe and Consultant may be referred to as “Parties.” Capitalized terms not defined herein will have the meanings ascribed to them in the Agreement.
